Financial Engines Advisors
NVIV

Financial Engines Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Financial Engines Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1
Closed -$25K – 237
2017
Q3 		$25K Buy
+1
New +$30.7K ﹤0.01% 88

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Financial Engines Advisors's NVIV Position: Q4 2017 in Review

Financial Engines Advisors sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q4 2017, closing a stake of 1 share — an estimated $25K sold.

Financial Engines Advisors first reported a position in NVIV in Q3 2017 and held it in 1 quarter. The position peaked at $25K in Q3 2017. 28 funds tracked by Wall St. Rank hold NVIV as of Q4 2017.

  • Financial Engines Advisors reported no remaining InVivo Therapeutics Holdings Corp position as of Q4 2017 after selling out during the quarter.
  • Financial Engines Advisors sold 1 InVivo Therapeutics Holdings Corp share in Q4 2017, an estimated $25K.
  • Financial Engines Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q3 2017 and held it in 1 quarter.
  • Financial Engines Advisors's InVivo Therapeutics Holdings Corp position peaked at $25K in Q3 2017.
  • 28 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2017.

Based on Financial Engines Advisors's 13F filing for Q4 2017, filed 2 Feb 2018.